296 related articles for article (PubMed ID: 19041428)
1. CD5: a safeguard against autoimmunity and a shield for cancer cells.
Dalloul A
Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
[TBL] [Abstract][Full Text] [Related]
2. Basic science for the clinician 54: CD5.
Sigal LH
J Clin Rheumatol; 2012 Mar; 18(2):83-8. PubMed ID: 22334268
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes are required for development and treatment of autoimmune diseases.
Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes on the front line of autoimmunity.
Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
[TBL] [Abstract][Full Text] [Related]
5. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.
Youinou P; Renaudineau Y
Thromb Res; 2004; 114(5-6):363-9. PubMed ID: 15507266
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional B cells in systemic lupus erythematosus.
Renaudineau Y; Pers JO; Bendaoud B; Jamin C; Youinou P
Autoimmun Rev; 2004 Nov; 3(7-8):516-23. PubMed ID: 15546800
[TBL] [Abstract][Full Text] [Related]
7. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
Youinou P; Renaudineau Y
Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
[TBL] [Abstract][Full Text] [Related]
8. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
[TBL] [Abstract][Full Text] [Related]
9. CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis.
Bataille R; Klein B
Anticancer Res; 1988; 8(4):707-10. PubMed ID: 2460021
[TBL] [Abstract][Full Text] [Related]
10. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity.
Ghia P; Scielzo C; Frenquelli M; Muzio M; Caligaris-Cappio F
Autoimmun Rev; 2007 Dec; 7(2):127-31. PubMed ID: 18035322
[TBL] [Abstract][Full Text] [Related]
11. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
12. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
[TBL] [Abstract][Full Text] [Related]
13. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and spectrum of autoimmunity.
Perl A
Methods Mol Med; 2004; 102():1-8. PubMed ID: 15286377
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells in autoimmune diseases: how do they work?
Lemoine S; Morva A; Youinou P; Jamin C
Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
[TBL] [Abstract][Full Text] [Related]
16. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
[TBL] [Abstract][Full Text] [Related]
17. Role of B-1a cells in autoimmunity.
Duan B; Morel L
Autoimmun Rev; 2006 Jul; 5(6):403-8. PubMed ID: 16890894
[TBL] [Abstract][Full Text] [Related]
18. Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.
Baglaenko Y; Manion KP; Chang NH; Loh C; Lajoie G; Wither JE
Genes Immun; 2015; 16(5):311-20. PubMed ID: 25973757
[TBL] [Abstract][Full Text] [Related]
19. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CD5 on B lymphocytes in cattle infected with Mycobacterium avium subsp. paratuberculosis.
Stabel JR; Khalifeh MS
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):211-9. PubMed ID: 18692906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
